title: Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?
authors.forename: Elaine
authors.initials: E
authors.lastname: Kingwell
authors.forename: Helen
authors.initials: H
authors.lastname: Tremlett
mesh_terms: D015897:Comorbidity; D019317:Evidence-Based Medicine / Q000639:trends*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D008954:Models, Biological; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology*; D009369:Neoplasms / Q000453:epidemiology*; D018570:Risk Assessment
chemical_list: D007155:Immunologic Factors; D016899:Interferon-beta